{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:46:08Z","timestamp":1793249168304,"version":"4.5.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s10286-014-0267-5","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T11:39:01Z","timestamp":1424173141000},"page":"19-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Multiple system atrophy: the application of genetics in understanding etiology"],"prefix":"10.1007","volume":"25","author":[{"given":"Monica","family":"Federoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia V.","family":"Schottlaender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Houlden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,17]]},"reference":[{"key":"267_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2990.2011.01234.x","volume":"38","author":"Z Ahmed","year":"2012","unstructured":"Ahmed Z, Asi YT, Sailer A et al (2012) The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol 38:4\u201324. doi: 10.1111\/j.1365-2990.2011.01234.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"267_CR2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S1474-4422(09)70288-1","volume":"8","author":"N Stefanova","year":"2009","unstructured":"Stefanova N, B\u00fccke P, Duerr S, Wenning GK (2009) Multiple system atrophy: an update. Lancet Neurol 8:1172\u20131178. doi: 10.1016\/S1474-4422(09)70288-1","journal-title":"Lancet Neurol"},{"key":"267_CR3","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.49.5.1284","volume":"49","author":"JH Bower","year":"1997","unstructured":"Bower JH, Maraganore DM, McDonnell SK, Rocca WA (1997) Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 49:1284\u20131288","journal-title":"Neurology"},{"key":"267_CR4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/jnnp.2003.025155","volume":"75","author":"U W\u00fcllner","year":"2004","unstructured":"W\u00fcllner U, Abele M, Schmitz-Huebsch T et al (2004) Probable multiple system atrophy in a German family. J Neurol Neurosurg Psychiatry 75:924\u2013925","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"267_CR5","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1212\/01.WNL.0000028690.15001.00","volume":"59","author":"Y Osaki","year":"2002","unstructured":"Osaki Y, Wenning GK, Daniel SE et al (2002) Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 59:1486\u20131491","journal-title":"Neurology"},{"key":"267_CR6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ana.21685","volume":"65","author":"SW Scholz","year":"2009","unstructured":"Scholz SW, Houlden H, Schulte C et al (2009) SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 65:610\u2013614. doi: 10.1002\/ana.21685","journal-title":"Ann Neurol"},{"key":"267_CR7","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670\u2013676. doi: 10.1212\/01.wnl.0000324625.00404.15","journal-title":"Neurology"},{"key":"267_CR8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archneur.64.4.545","volume":"64","author":"K Hara","year":"2007","unstructured":"Hara K, Momose Y, Tokiguchi S et al (2007) Multiplex families with multiple system atrophy. Arch Neurol 64:545\u2013551. doi: 10.1001\/archneur.64.4.545","journal-title":"Arch Neurol"},{"key":"267_CR9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","volume":"125","author":"AP Kiely","year":"2013","unstructured":"Kiely AP, Asi YT, Kara E et al (2013) \u03b1-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson\u2019s disease and multiple system atrophy? Acta Neuropathol (Berl) 125:753\u2013769. doi: 10.1007\/s00401-013-1096-7","journal-title":"Acta Neuropathol (Berl)"},{"key":"267_CR10","doi-asserted-by":"crossref","first-page":"838","DOI":"10.5692\/clinicalneurol.51.838","volume":"51","author":"M Yoshida","year":"2011","unstructured":"Yoshida M (2011) Multiple system atrophy\u2014synuclein and neuronal degeneration. Rinsh\u014d Shinkeigaku Clin Neurol 51:838\u2013842","journal-title":"Rinsh\u014d Shinkeigaku Clin Neurol"},{"key":"267_CR11","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1136\/jnnp.2009.182576","volume":"81","author":"T Ozawa","year":"2010","unstructured":"Ozawa T, Tada M, Kakita A et al (2010) The phenotype spectrum of Japanese multiple system atrophy. J Neurol Neurosurg Psychiatry 81:1253\u20131255. doi: 10.1136\/jnnp.2009.182576","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"267_CR12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0140-6736(93)91789-O","volume":"342","author":"GK Wenning","year":"1993","unstructured":"Wenning GK, Wagner S, Daniel S, Quinn NP (1993) Multiple system atrophy: sporadic or familial? Lancet 342:681","journal-title":"Lancet"},{"key":"267_CR13","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00702-005-0380-7","volume":"112","author":"N Vanacore","year":"2005","unstructured":"Vanacore N (2005) Epidemiological evidence on multiple system atrophy. J Neural Transm 112:1605\u20131612. doi: 10.1007\/s00702-005-0380-7","journal-title":"J Neural Transm"},{"key":"267_CR14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0034-1381738","volume":"34","author":"BL Fogel","year":"2014","unstructured":"Fogel BL, Clark MC, Geschwind DH (2014) The neurogenetics of atypical parkinsonian disorders. Semin Neurol 34:217\u2013224. doi: 10.1055\/s-0034-1381738","journal-title":"Semin Neurol"},{"key":"267_CR15","author":"M Stamelou","year":"2013","unstructured":"Stamelou M, Quinn NP, Bhatia KP (2013) \u201cAtypical\u201d atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy\u2014a diagnostic guide. Mov Disord Off J Mov Disord Soc. doi: 10.1002\/mds.25509","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1474-4422(12)70327-7","volume":"12","author":"GK Wenning","year":"2013","unstructured":"Wenning GK, Geser F, Krismer F et al (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12:264\u2013274. doi: 10.1016\/S1474-4422(12)70327-7","journal-title":"Lancet Neurol"},{"key":"267_CR17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.410390214","volume":"39","author":"S Gilman","year":"1996","unstructured":"Gilman S, Sima AA, Junck L et al (1996) Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions. Ann Neurol 39:241\u2013255. doi: 10.1002\/ana.410390214","journal-title":"Ann Neurol"},{"key":"267_CR18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/mds.21231","volume":"22","author":"MJ Nirenberg","year":"2007","unstructured":"Nirenberg MJ, Libien J, Vonsattel J-P, Fahn S (2007) Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutation. Mov Disord Off J Mov Disord Soc 22:251\u2013254. doi: 10.1002\/mds.21231","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.parkreldis.2006.01.002","volume":"12","author":"Y Huang","year":"2006","unstructured":"Huang Y, Hayes M, Harding AJ et al (2006) Anticipation of onset age in familial Parkinson\u2019s disease without SCA gene mutations. Parkinsonism Relat Disord 12:309\u2013313. doi: 10.1016\/j.parkreldis.2006.01.002","journal-title":"Parkinsonism Relat Disord"},{"key":"267_CR20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(04)00737-9","volume":"3","author":"L Sch\u00f6ls","year":"2004","unstructured":"Sch\u00f6ls L, Bauer P, Schmidt T et al (2004) Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 3:291\u2013304. doi: 10.1016\/S1474-4422(04)00737-9","journal-title":"Lancet Neurol"},{"key":"267_CR21","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/mds.20564","volume":"20","author":"NL Khan","year":"2005","unstructured":"Khan NL, Giunti P, Sweeney MG et al (2005) Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6). Mov Disord Off J Mov Disord Soc 20:1115\u20131119. doi: 10.1002\/mds.20564","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR22","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.0b013e3181a18876","volume":"72","author":"J-Y Kim","year":"2009","unstructured":"Kim J-Y, Kim SY, Kim J-M et al (2009) Spinocerebellar ataxia type 17 mutation as a causative and susceptibility gene in parkinsonism. Neurology 72:1385\u20131389. doi: 10.1212\/WNL.0b013e3181a18876","journal-title":"Neurology"},{"key":"267_CR23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/brain\/awf107","volume":"125","author":"M Abele","year":"2002","unstructured":"Abele M, B\u00fcrk K, Sch\u00f6ls L et al (2002) The aetiology of sporadic adult-onset ataxia. Brain J Neurol 125:961\u2013968","journal-title":"Brain J Neurol"},{"key":"267_CR24","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.parkreldis.2006.04.009","volume":"13","author":"I-S Lin","year":"2007","unstructured":"Lin I-S, Wu R-M, Lee-Chen G-J et al (2007) The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment. Parkinsonism Relat Disord 13:246\u2013249. doi: 10.1016\/j.parkreldis.2006.04.009","journal-title":"Parkinsonism Relat Disord"},{"key":"267_CR25","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1212\/WNL.0000000000000965","volume":"83","author":"H-J Kim","year":"2014","unstructured":"Kim H-J, Jeon BS, Shin J et al (2014) Should genetic testing for SCAs be included in the diagnostic workup for MSA? Neurology 83:1733\u20131738. doi: 10.1212\/WNL.0000000000000965","journal-title":"Neurology"},{"issue":"1924","key":"267_CR26","first-page":"e5","volume":"32","author":"S Stemberger","year":"2011","unstructured":"Stemberger S, Scholz SW, Singleton AB, Wenning GK (2011) Genetic players in multiple system atrophy: unfolding the nature of the beast. Neurobiol Aging 32(1924):e5\u2013e14. doi: 10.1016\/j.neurobiolaging.2011.04.001","journal-title":"Neurobiol Aging"},{"key":"267_CR27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00702-010-0576-3","volume":"118","author":"S Stemberger","year":"2011","unstructured":"Stemberger S, Wenning GK (2011) Modelling progressive autonomic failure in MSA: where are we now? J Neural Transm 118:841\u2013847. doi: 10.1007\/s00702-010-0576-3","journal-title":"J Neural Transm"},{"key":"267_CR28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuroscience.2011.09.044","volume":"211","author":"P-O Fernagut","year":"2012","unstructured":"Fernagut P-O, Tison F (2012) Animal models of multiple system atrophy. Neuroscience 211:77\u201382. doi: 10.1016\/j.neuroscience.2011.09.044","journal-title":"Neuroscience"},{"key":"267_CR29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1756285610375328","volume":"3","author":"O Flabeau","year":"2010","unstructured":"Flabeau O, Meissner WG, Tison F (2010) Multiple system atrophy: current and future approaches to management. Ther Adv Neurol Disord 3:249\u2013263. doi: 10.1177\/1756285610375328","journal-title":"Ther Adv Neurol Disord"},{"key":"267_CR30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/jnnp.68.4.434","volume":"68","author":"GK Wenning","year":"2000","unstructured":"Wenning GK, Ben-Shlomo Y, Hughes A et al (2000) What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson\u2019s disease? J Neurol Neurosurg Psychiatry 68:434\u2013440","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"267_CR31","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/brain\/awh303","volume":"127","author":"T Ozawa","year":"2004","unstructured":"Ozawa T, Paviour D, Quinn NP et al (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain J Neurol 127:2657\u20132671. doi: 10.1093\/brain\/awh303","journal-title":"Brain J Neurol"},{"key":"267_CR32","doi-asserted-by":"crossref","first-page":"e46817","DOI":"10.1371\/journal.pone.0046817","volume":"7","author":"H Kisos","year":"2012","unstructured":"Kisos H, Puka\u00df K, Ben-Hur T et al (2012) Increased neuronal \u03b1-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling \u03b1-synucleinopathies. PLoS One 7:e46817. doi: 10.1371\/journal.pone.0046817","journal-title":"PLoS One"},{"key":"267_CR33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/WNR.0b013e3283509842","volume":"23","author":"E Rockenstein","year":"2012","unstructured":"Rockenstein E, Ubhi K, Inglis C et al (2012) Neuronal to oligodendroglial \u03b1-synuclein redistribution in a double transgenic model of multiple system atrophy. Neuroreport 23:259\u2013264. doi: 10.1097\/WNR.0b013e3283509842","journal-title":"Neuroreport"},{"key":"267_CR34","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1440-1789.2007.00841.x","volume":"27","author":"M Yoshida","year":"2007","unstructured":"Yoshida M (2007) Multiple system atrophy: alpha-synuclein and neuronal degeneration. Neuropathol Off J Jpn Soc Neuropathol 27:484\u2013493","journal-title":"Neuropathol Off J Jpn Soc Neuropathol"},{"key":"267_CR35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s004010000214","volume":"100","author":"S Kato","year":"2000","unstructured":"Kato S, Shinozawa T, Takikawa M et al (2000) Midkine, a new neurotrophic factor, is present in glial cytoplasmic inclusions of multiple system atrophy brains. Acta Neuropathol (Berl) 100:481\u2013489","journal-title":"Acta Neuropathol (Berl)"},{"key":"267_CR36","doi-asserted-by":"crossref","unstructured":"Muramatsu T (1992) Retinoic acid regulates the expression of a new heparin binding growth differentiation factor. J Nutr Sci Vitaminol (Tokyo) Spec No:485\u2013487","DOI":"10.3177\/jnsv.38.Special_485"},{"key":"267_CR37","first-page":"1175","volume":"116","author":"V Nurcombe","year":"1992","unstructured":"Nurcombe V, Fraser N, Herlaar E, Heath JK (1992) MK: a pluripotential embryonic stem-cell-derived neuroregulatory factor. Dev Camb Engl 116:1175\u20131183","journal-title":"Dev Camb Engl"},{"key":"267_CR38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0165-3806(93)90024-5","volume":"75","author":"J Satoh","year":"1993","unstructured":"Satoh J, Muramatsu H, Moretto G et al (1993) Midkine that promotes survival of fetal human neurons is produced by fetal human astrocytes in culture. Brain Res Dev Brain Res 75:201\u2013205","journal-title":"Brain Res Dev Brain Res"},{"key":"267_CR39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jnen\/63.1.43","volume":"63","author":"K Ishizawa","year":"2004","unstructured":"Ishizawa K, Komori T, Sasaki S et al (2004) Microglial activation parallels system degeneration in multiple system atrophy. J Neuropathol Exp Neurol 63:43\u201352","journal-title":"J Neuropathol Exp Neurol"},{"key":"267_CR40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/glia.20909","volume":"58","author":"A Lehotzky","year":"2010","unstructured":"Lehotzky A, Lau P, Tok\u00e9si N et al (2010) Tubulin polymerization-promoting protein (TPPP\/p25) is critical for oligodendrocyte differentiation. Glia 58:157\u2013168. doi: 10.1002\/glia.20909","journal-title":"Glia"},{"key":"267_CR41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuint.2010.09.002","volume":"57","author":"T Hasegawa","year":"2010","unstructured":"Hasegawa T, Baba T, Kobayashi M et al (2010) Role of TPPP\/p25 on \u03b1-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy. Neurochem Int 57:857\u2013866. doi: 10.1016\/j.neuint.2010.09.002","journal-title":"Neurochem Int"},{"key":"267_CR42","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2353\/ajpath.2007.070201","volume":"171","author":"YJC Song","year":"2007","unstructured":"Song YJC, Lundvig DMS, Huang Y et al (2007) p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Am J Pathol 171:1291\u20131303. doi: 10.2353\/ajpath.2007.070201","journal-title":"Am J Pathol"},{"key":"267_CR43","doi-asserted-by":"crossref","first-page":"23179","DOI":"10.1074\/jbc.M802223200","volume":"283","author":"N Sugeno","year":"2008","unstructured":"Sugeno N, Takeda A, Hasegawa T et al (2008) Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death. J Biol Chem 283:23179\u201323188. doi: 10.1074\/jbc.M802223200","journal-title":"J Biol Chem"},{"key":"267_CR44","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s12031-010-9439-5","volume":"43","author":"M Riedel","year":"2011","unstructured":"Riedel M, Goldbaum O, Wille M, Richter-Landsberg C (2011) Membrane lipid modification by docosahexaenoic acid (DHA) promotes the formation of \u03b1-synuclein inclusion bodies immunopositive for SUMO-1 in oligodendroglial cells after oxidative stress. J Mol Neurosci MN 43:290\u2013302. doi: 10.1007\/s12031-010-9439-5","journal-title":"J Mol Neurosci MN"},{"key":"267_CR45","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.1143780","volume":"317","author":"TF Outeiro","year":"2007","unstructured":"Outeiro TF, Kontopoulos E, Altmann SM et al (2007) Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson\u2019s disease. Science 317:516\u2013519. doi: 10.1126\/science.1143780","journal-title":"Science"},{"key":"267_CR46","first-page":"7","volume":"2","author":"T Ozawa","year":"2012","unstructured":"Ozawa T, Revesz T, Paviour D et al (2012) Difference in MSA phenotype distribution between populations: genetics or environment? J Park Dis 2:7\u201318. doi: 10.3233\/JPD-2012-11056","journal-title":"J Park Dis"},{"key":"267_CR47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF01826052","volume":"1","author":"LE Nee","year":"1991","unstructured":"Nee LE, Gomez MR, Dambrosia J et al (1991) Environmental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation. Clin Auton Res Off J Clin Auton Res Soc 1:9\u201313","journal-title":"Clin Auton Res Off J Clin Auton Res Soc"},{"key":"267_CR48","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/mds.20303","volume":"20","author":"N Vanacore","year":"2005","unstructured":"Vanacore N, Bonifati V, Fabbrini G et al (2005) Case-control study of multiple system atrophy. Mov Disord Off J Mov Disord Soc 20:158\u2013163. doi: 10.1002\/mds.20303","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR49","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson WS, Jonas A, Clayton DF, George JM (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273:9443\u20139449","journal-title":"J Biol Chem"},{"key":"267_CR50","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/mds.22459","volume":"24","author":"PH Lee","year":"2009","unstructured":"Lee PH, Lim TS, Shin H-W et al (2009) Serum cholesterol levels and the risk of multiple system atrophy: a case-control study. Mov Disord Off J Mov Disord Soc 24:752\u2013758. doi: 10.1002\/mds.22459","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR51","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.parkreldis.2006.02.005","volume":"12","author":"RA Armstrong","year":"2006","unstructured":"Armstrong RA, Cairns NJ, Lantos PL (2006) Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes. Parkinsonism Relat Disord 12:356\u2013362. doi: 10.1016\/j.parkreldis.2006.02.005","journal-title":"Parkinsonism Relat Disord"},{"key":"267_CR52","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1007\/s00415-010-5638-9","volume":"257","author":"J-S Vidal","year":"2010","unstructured":"Vidal J-S, Vidailhet M, Derkinderen P et al (2010) Familial aggregation in atypical Parkinson\u2019s disease: a case control study in multiple system atrophy and progressive supranuclear palsy. J Neurol 257:1388\u20131393. doi: 10.1007\/s00415-010-5638-9","journal-title":"J Neurol"},{"key":"267_CR53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1212115","volume":"369","author":"Multiple-System Atrophy Research Collaboration","year":"2013","unstructured":"Multiple-System Atrophy Research Collaboration (2013) Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med 369:233\u2013244. doi: 10.1056\/NEJMoa1212115","journal-title":"N Engl J Med"},{"key":"267_CR54","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJMc1311763","volume":"371","author":"BS Jeon","year":"2014","unstructured":"Jeon BS, Farrer MJ, Bortnick SF, Korean Canadian Alliance on Parkinson\u2019s Disease and Related Disorders (2014) Mutant COQ2 in multiple-system atrophy. N Engl J Med 371:80. doi: 10.1056\/NEJMc1311763#SA1","journal-title":"N Engl J Med"},{"key":"267_CR55","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJMc1311763","volume":"371","author":"M Sharma","year":"2014","unstructured":"Sharma M, Wenning G, Kr\u00fcger R, European Multiple-System Atrophy Study Group (EMSA-SG) (2014) Mutant COQ2 in multiple-system atrophy. N Engl J Med 371:80\u201381. doi: 10.1056\/NEJMc1311763#SA2","journal-title":"N Engl J Med"},{"key":"267_CR56","first-page":"81","volume":"371","author":"LV Schottlaender","year":"2014","unstructured":"Schottlaender LV, Houlden H, Multiple-System Atrophy (MSA) Brain Bank Collaboration (2014) Mutant COQ2 in multiple-system atrophy. N Engl J Med 371:81. doi: 10.1056\/NEJMc1311763#SA3","journal-title":"N Engl J Med"},{"key":"267_CR57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2051-5960-2-15","volume":"2","author":"JM Bleasel","year":"2014","unstructured":"Bleasel JM, Wong JH, Halliday GM, Kim WS (2014) Lipid dysfunction and pathogenesis of multiple system atrophy. Acta Neuropathol Commun 2:15. doi: 10.1186\/2051-5960-2-15","journal-title":"Acta Neuropathol Commun"},{"key":"267_CR58","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/mds.22046","volume":"23","author":"H Soma","year":"2008","unstructured":"Soma H, Yabe I, Takei A et al (2008) Associations between multiple system atrophy and polymorphisms of SLC1A4, SQSTM1, and EIF4EBP1 genes. Mov Disord Off J Mov Disord Soc 23:1161\u20131167. doi: 10.1002\/mds.22046","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR59","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","volume":"35","author":"T Wyss-Coray","year":"2002","unstructured":"Wyss-Coray T, Mucke L (2002) Inflammation in neurodegenerative disease\u2014a double-edged sword. Neuron 35:419\u2013432","journal-title":"Neuron"},{"key":"267_CR60","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/mds.10540","volume":"18","author":"O Combarros","year":"2003","unstructured":"Combarros O, Infante J, Llorca J, Berciano J (2003) Interleukin-1A (-889) genetic polymorphism increases the risk of multiple system atrophy. Mov Disord Off J Mov Disord Soc 18:1385\u20131386. doi: 10.1002\/mds.10540","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR61","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/mds.10124","volume":"17","author":"M Nishimura","year":"2002","unstructured":"Nishimura M, Kawakami H, Komure O et al (2002) Contribution of the interleukin-1beta gene polymorphism in multiple system atrophy. Mov Disord Off J Mov Disord Soc 17:808\u2013811. doi: 10.1002\/mds.10124","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jns.2004.09.023","volume":"228","author":"J Infante","year":"2005","unstructured":"Infante J, Llorca J, Berciano J, Combarros O (2005) Interleukin-8, intercellular adhesion molecule-1 and tumour necrosis factor-alpha gene polymorphisms and the risk for multiple system atrophy. J Neurol Sci 228:11\u201313. doi: 10.1016\/j.jns.2004.09.023","journal-title":"J Neurol Sci"},{"key":"267_CR63","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.molbrainres.2005.04.011","volume":"138","author":"Y Furiya","year":"2005","unstructured":"Furiya Y, Hirano M, Kurumatani N et al (2005) Alpha-1-antichymotrypsin gene polymorphism and susceptibility to multiple system atrophy (MSA). Brain Res Mol Brain Res 138:178\u2013181. doi: 10.1016\/j.molbrainres.2005.04.011","journal-title":"Brain Res Mol Brain Res"},{"key":"267_CR64","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neulet.2004.10.056","volume":"374","author":"M Nishimura","year":"2005","unstructured":"Nishimura M, Kuno S, Kaji R, Kawakami H (2005) Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy. Neurosci Lett 374:218\u2013221. doi: 10.1016\/j.neulet.2004.10.056","journal-title":"Neurosci Lett"},{"key":"267_CR65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10286-007-0447-7","volume":"18","author":"C Shibao","year":"2008","unstructured":"Shibao C, Garland EM, Gamboa A et al (2008) PRNP M129\u00a0V homozygosity in multiple system atrophy vs. Parkinson\u2019s disease. Clin Auton Res Off J Clin Auton Res Soc 18:13\u201319. doi: 10.1007\/s10286-007-0447-7","journal-title":"Clin Auton Res Off J Clin Auton Res Soc"},{"key":"267_CR66","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00401-001-0499-z","volume":"103","author":"S Ha\u00efk","year":"2002","unstructured":"Ha\u00efk S, Privat N, Adjou KT et al (2002) Alpha-synuclein-immunoreactive deposits in human and animal prion diseases. Acta Neuropathol (Berl) 103:516\u2013520. doi: 10.1007\/s00401-001-0499-z","journal-title":"Acta Neuropathol (Berl)"},{"key":"267_CR67","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/jnnp.57.10.1249","volume":"57","author":"K Jendroska","year":"1994","unstructured":"Jendroska K, Hoffmann O, Schelosky L et al (1994) Absence of disease related prion protein in neurodegenerative disorders presenting with Parkinson\u2019s syndrome. J Neurol Neurosurg Psychiatry 57:1249\u20131251","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"267_CR68","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J et al (2003) alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841. doi: 10.1126\/science.1090278","journal-title":"Science"},{"key":"267_CR69","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.10846","volume":"55","author":"M Farrer","year":"2004","unstructured":"Farrer M, Kachergus J, Forno L et al (2004) Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55:174\u2013179. doi: 10.1002\/ana.10846","journal-title":"Ann Neurol"},{"key":"267_CR70","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neulet.2005.07.044","volume":"389","author":"D Hernandez","year":"2005","unstructured":"Hernandez D, Paisan Ruiz C, Crawley A et al (2005) The dardarin G 2019 S mutation is a common cause of Parkinson\u2019s disease but not other neurodegenerative diseases. Neurosci Lett 389:137\u2013139. doi: 10.1016\/j.neulet.2005.07.044","journal-title":"Neurosci Lett"},{"key":"267_CR71","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.parkreldis.2006.12.005","volume":"13","author":"SJ Lincoln","year":"2007","unstructured":"Lincoln SJ, Ross OA, Milkovic NM et al (2007) Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy. Parkinsonism Relat Disord 13:340\u2013342. doi: 10.1016\/j.parkreldis.2006.12.005","journal-title":"Parkinsonism Relat Disord"},{"key":"267_CR72","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1212\/WNL.55.12.1918","volume":"55","author":"HR Morris","year":"2000","unstructured":"Morris HR, Vaughan JR, Datta SR et al (2000) Multiple system atrophy\/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE. Neurology 55:1918\u20131920","journal-title":"Neurology"},{"key":"267_CR73","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0304-3940(99)00475-9","volume":"270","author":"T Ozawa","year":"1999","unstructured":"Ozawa T, Takano H, Onodera O et al (1999) No mutation in the entire coding region of the alpha-synuclein gene in pathologically confirmed cases of multiple system atrophy. Neurosci Lett 270:110\u2013112","journal-title":"Neurosci Lett"},{"key":"267_CR74","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/jnnp.2005.073528","volume":"77","author":"T Ozawa","year":"2006","unstructured":"Ozawa T, Healy DG, Abou-Sleiman PM et al (2006) The alpha-synuclein gene in multiple system atrophy. J Neurol Neurosurg Psychiatry 77:464\u2013467. doi: 10.1136\/jnnp.2005.073528","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"267_CR75","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s004010100367","volume":"102","author":"T Ozawa","year":"2001","unstructured":"Ozawa T, Okuizumi K, Ikeuchi T et al (2001) Analysis of the expression level of alpha-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy. Acta Neuropathol (Berl) 102:188\u2013190","journal-title":"Acta Neuropathol (Berl)"},{"key":"267_CR76","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.expneurol.2006.01.008","volume":"199","author":"IR Vogt","year":"2006","unstructured":"Vogt IR, Lees AJ, Evert BO et al (2006) Transcriptional changes in multiple system atrophy and Parkinson\u2019s disease putamen. Exp Neurol 199:465\u2013478. doi: 10.1016\/j.expneurol.2006.01.008","journal-title":"Exp Neurol"},{"key":"267_CR77","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/mds.21259","volume":"22","author":"AJ Langerveld","year":"2007","unstructured":"Langerveld AJ, Mihalko D, DeLong C et al (2007) Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients. Mov Disord Off J Mov Disord Soc 22:766\u2013777. doi: 10.1002\/mds.21259","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR78","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ana.21786","volume":"67","author":"OA Ross","year":"2010","unstructured":"Ross OA, Vilari\u00f1o-G\u00fcell C, Wszolek ZK et al (2010) Reply to: SNCA variants are associated with increased risk of multiple system atrophy. Ann Neurol 67:414\u2013415. doi: 10.1002\/ana.21786","journal-title":"Ann Neurol"},{"key":"267_CR79","doi-asserted-by":"crossref","first-page":"e7114","DOI":"10.1371\/journal.pone.0007114","volume":"4","author":"A Al-Chalabi","year":"2009","unstructured":"Al-Chalabi A, D\u00fcrr A, Wood NW et al (2009) Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS One 4:e7114. doi: 10.1371\/journal.pone.0007114","journal-title":"PLoS One"},{"key":"267_CR80","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Sim\u00f3n-S\u00e1nchez","year":"2009","unstructured":"Sim\u00f3n-S\u00e1nchez J, Schulte C, Bras JM et al (2009) Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet 41:1308\u20131312. doi: 10.1038\/ng.487","journal-title":"Nat Genet"},{"key":"267_CR81","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ng.485","volume":"41","author":"W Satake","year":"2009","unstructured":"Satake W, Nakabayashi Y, Mizuta I et al (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease. Nat Genet 41:1303\u20131307. doi: 10.1038\/ng.485","journal-title":"Nat Genet"},{"key":"267_CR82","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.21889","volume":"67","author":"JY Yun","year":"2010","unstructured":"Yun JY, Lee W-W, Lee J-Y et al (2010) SNCA variants and multiple system atrophy. Ann Neurol 67:554\u2013555. doi: 10.1002\/ana.21889","journal-title":"Ann Neurol"},{"key":"267_CR83","author":"XY Guo","year":"2014","unstructured":"Guo XY, Chen YP, Song W et al (2014) SNCA variants rs2736990 and rs356220 as risk factors for Parkinson\u2019s disease but not for amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population. Neurobiol Aging. doi: 10.1016\/j.neurobiolaging.2014.07.014","journal-title":"Neurobiol Aging"},{"key":"267_CR84","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1001\/archneurol.2011.924","volume":"69","author":"Z Gan-Or","year":"2012","unstructured":"Gan-Or Z, Bar-Shira A, Dahary D et al (2012) Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk. Arch Neurol 69:105\u2013110. doi: 10.1001\/archneurol.2011.924","journal-title":"Arch Neurol"},{"key":"267_CR85","first-page":"1337","volume":"21","author":"X-Y Guo","year":"2014","unstructured":"Guo X-Y, Chen Y-P, Song W et al (2014) An association analysis of the rs1572931 polymorphism of the RAB7L1 gene in Parkinson\u2019s disease, amyotrophic lateral sclerosis and multiple system atrophy in China. Eur J Neurol Off J Eur Fed Neurol Soc 21:1337\u20131343. doi: 10.1111\/ene.12490","journal-title":"Eur J Neurol Off J Eur Fed Neurol Soc"},{"key":"267_CR86","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/WNL.0b013e31820c30c1","volume":"76","author":"C Vilari\u00f1o-G\u00fcell","year":"2011","unstructured":"Vilari\u00f1o-G\u00fcell C, Soto-Ortolaza AI, Rajput A et al (2011) MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy. Neurology 76:670\u2013672. doi: 10.1212\/WNL.0b013e31820c30c1","journal-title":"Neurology"},{"key":"267_CR87","first-page":"483","volume":"17","author":"C Wider","year":"2010","unstructured":"Wider C, Vilari\u00f1o-G\u00fcell C, Jasinska-Myga B et al (2010) Association of the MAPT locus with Parkinson\u2019s disease. Eur J Neurol Off J Eur Fed Neurol Soc 17:483\u2013486. doi: 10.1111\/j.1468-1331.2009.02847.x","journal-title":"Eur J Neurol Off J Eur Fed Neurol Soc"},{"key":"267_CR88","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO et al (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med 361:1651\u20131661. doi: 10.1056\/NEJMoa0901281","journal-title":"N Engl J Med"},{"key":"267_CR89","first-page":"e61","volume":"20","author":"K Srulijes","year":"2013","unstructured":"Srulijes K, Hauser A-K, Guella I et al (2013) No association of GBA mutations and multiple system atrophy. Eur J Neurol Off J Eur Fed Neurol Soc 20:e61\u2013e62. doi: 10.1111\/ene.12086","journal-title":"Eur J Neurol Off J Eur Fed Neurol Soc"},{"key":"267_CR90","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/01.wnl.0000345356.40399.eb","volume":"72","author":"B Segarane","year":"2009","unstructured":"Segarane B, Li A, Paudel R et al (2009) Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology 72:1185\u20131186. doi: 10.1212\/01.wnl.0000345356.40399.eb","journal-title":"Neurology"},{"key":"267_CR91","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/mds.21343","volume":"22","author":"LJ Ozelius","year":"2007","unstructured":"Ozelius LJ, Foroud T, May S et al (2007) G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy. Mov Disord Off J Mov Disord Soc 22:546\u2013549. doi: 10.1002\/mds.21343","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR92","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/mds.20875","volume":"21","author":"EK Tan","year":"2006","unstructured":"Tan EK, Skipper L, Chua E et al (2006) Analysis of 14 LRRK2 mutations in Parkinson\u2019s plus syndromes and late-onset Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 21:997\u20131001. doi: 10.1002\/mds.20875","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR93","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1212\/WNL.0000000000001078","volume":"83","author":"MG Heckman","year":"2014","unstructured":"Heckman MG, Schottlaender L, Soto-Ortolaza AI et al (2014) LRRK2 exonic variants and risk of multiple system atrophy. Neurology 83:2256\u20132261. doi: 10.1212\/WNL.0000000000001078","journal-title":"Neurology"},{"key":"267_CR94","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1471-4159.2009.06403.x","volume":"111","author":"T Hatano","year":"2009","unstructured":"Hatano T, Kubo S, Sato S, Hattori N (2009) Pathogenesis of familial Parkinson\u2019s disease: new insights based on monogenic forms of Parkinson\u2019s disease. J Neurochem 111:1075\u20131093. doi: 10.1111\/j.1471-4159.2009.06403.x","journal-title":"J Neurochem"},{"issue":"548","key":"267_CR95","first-page":"e5","volume":"32","author":"JA Brooks","year":"2011","unstructured":"Brooks JA, Houlden H, Melchers A et al (2011) Mutational analysis of parkin and PINK1 in multiple system atrophy. Neurobiol Aging 32(548):e5\u2013e7. doi: 10.1016\/j.neurobiolaging.2009.11.020","journal-title":"Neurobiol Aging"},{"key":"267_CR96","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/1531-8257(200009)15:5<813::AID-MDS1008>3.0.CO;2-Y","volume":"15","author":"S Buervenich","year":"2000","unstructured":"Buervenich S, Sydow O, Carmine A et al (2000) Alcohol dehydrogenase alleles in Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 15:813\u2013818","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR97","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/archneur.62.1.74","volume":"62","author":"S Buervenich","year":"2005","unstructured":"Buervenich S, Carmine A, Galter D et al (2005) A rare truncating mutation in ADH1C (G78Stop) shows significant association with Parkinson disease in a large international sample. Arch Neurol 62:74\u201378. doi: 10.1001\/archneur.62.1.74","journal-title":"Arch Neurol"},{"key":"267_CR98","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00441-004-0917-3","volume":"318","author":"DG Healy","year":"2004","unstructured":"Healy DG, Abou-Sleiman PM, Wood NW (2004) Genetic causes of Parkinson\u2019s disease: UCHL-1. Cell Tissue Res 318:189\u2013194. doi: 10.1007\/s00441-004-0917-3","journal-title":"Cell Tissue Res"},{"key":"267_CR99","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/mds.10500","volume":"18","author":"HS Kim","year":"2003","unstructured":"Kim HS, Lee MS (2003) Frequencies of single nucleotide polymorphism in alcohol dehydrogenase7 gene in patients with multiple system atrophy and controls. Mov Disord Off J Mov Disord Soc 18:1065\u20131067. doi: 10.1002\/mds.10500","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR100","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/mds.20575","volume":"20","author":"DG Healy","year":"2005","unstructured":"Healy DG, Abou-Sleiman PM, Quinn N et al (2005) UCHL-1 gene in multiple system atrophy: a haplotype tagging approach. Mov Disord Off J Mov Disord Soc 20:1338\u20131343. doi: 10.1002\/mds.20575","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR101","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE, Majounie E, Waite A et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257\u2013268. doi: 10.1016\/j.neuron.2011.09.010","journal-title":"Neuron"},{"key":"267_CR102","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/jamaneurol.2013.5762","volume":"71","author":"JS Goldman","year":"2014","unstructured":"Goldman JS, Quinzii C, Dunning-Broadbent J et al (2014) Multiple system atrophy and amyotrophic lateral sclerosis in a family with hexanucleotide repeat expansions in C9orf72. JAMA Neurol 71:771\u2013774. doi: 10.1001\/jamaneurol.2013.5762","journal-title":"JAMA Neurol"},{"key":"267_CR103","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jamaneurol.2014.1808","volume":"71","author":"LV Schottlaender","year":"2014","unstructured":"Schottlaender LV, Holton JL, Houlden H (2014) Multiple system atrophy and repeat expansions in c9orf72. JAMA Neurol 71:1190\u20131191. doi: 10.1001\/jamaneurol.2014.1808","journal-title":"JAMA Neurol"},{"key":"267_CR104","author":"SW Scholz","year":"2014","unstructured":"Scholz SW, Majounie E, Revesz T et al (2014) Multiple system atrophy is not caused by C9orf72 hexanucleotide repeat expansions. Neurobiol Aging. doi: 10.1016\/j.neurobiolaging.2014.08.033","journal-title":"Neurobiol Aging"},{"key":"267_CR105","author":"L Schottlaender","year":"2014","unstructured":"Schottlaender L, Polke JM, Ling H et al (2014) The analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism. Neurobiol Aging. doi: 10.1016\/j.neurobiolaging.2014.08.024","journal-title":"Neurobiol Aging"},{"key":"267_CR106","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1017\/S0317167100121006","volume":"29","author":"K Chu","year":"2002","unstructured":"Chu K, Cho J-W, Song E-C, Jeon BS (2002) A patient with proximal myotonic myopathy and parkinsonism. Can J Neurol Sci J Can Sci Neurol 29:188\u2013190","journal-title":"Can J Neurol Sci J Can Sci Neurol"},{"key":"267_CR107","first-page":"275","volume":"13","author":"Y Celik","year":"2006","unstructured":"Celik Y, Turgut N, Balci K, Kabayel L (2006) Proximal myotonic dystrophy associated with parkinsonism. J Clin Neurosci Off J Neurosurg Soc Australas 13:275\u2013276. doi: 10.1016\/j.jocn.2005.01.013","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"267_CR108","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/mds.22239","volume":"23","author":"A Annic","year":"2008","unstructured":"Annic A, Devos D, Dest\u00e9e A et al (2008) Early dopasensitive Parkinsonism related to myotonic dystrophy type 2. Mov Disord Off J Mov Disord Soc 23:2100\u20132101. doi: 10.1002\/mds.22239","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR109","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jnnp.2005.078451","volume":"77","author":"V Sansone","year":"2006","unstructured":"Sansone V, Meola G, Perani D et al (2006) Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism. J Neurol Neurosurg Psychiatry 77:425\u2013426. doi: 10.1136\/jnnp.2005.078451","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"267_CR110","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/mds.22625","volume":"24","author":"S-Y Lim","year":"2009","unstructured":"Lim S-Y, Wadia P, Wenning GK, Lang AE (2009) Clinically probable multiple system atrophy with predominant parkinsonism associated with myotonic dystrophy type 2. Mov Disord Off J Mov Disord Soc 24:1407\u20131409. doi: 10.1002\/mds.22625","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR111","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ajmg.a.20194","volume":"120A","author":"S Cho","year":"2003","unstructured":"Cho S, Kim C-H, Cubells JF et al (2003) Variations in the dopamine beta-hydroxylase gene are not associated with the autonomic disorders, pure autonomic failure, or multiple system atrophy. Am J Med Genet A 120A:234\u2013236. doi: 10.1002\/ajmg.a.20194","journal-title":"Am J Med Genet A"},{"key":"267_CR112","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.nbd.2012.02.002","volume":"46","author":"M Federoff","year":"2012","unstructured":"Federoff M, Jimenez-Rolando B, Nalls MA, Singleton AB (2012) A large study reveals no association between APOE and Parkinson\u2019s disease. Neurobiol Dis 46:389\u2013392. doi: 10.1016\/j.nbd.2012.02.002","journal-title":"Neurobiol Dis"},{"key":"267_CR113","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(96)13316-4","volume":"221","author":"NJ Cairns","year":"1997","unstructured":"Cairns NJ, Atkinson PF, Kov\u00e1cs T et al (1997) Apolipoprotein E e4 allele frequency in patients with multiple system atrophy. Neurosci Lett 221:161\u2013164","journal-title":"Neurosci Lett"},{"key":"267_CR114","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s13760-013-0223-5","volume":"114","author":"M Multhammer","year":"2014","unstructured":"Multhammer M, Michels A, Zintl M et al (2014) A large ApoE \u03b54\/\u03b54 homozygous cohort reveals no association with Parkinson\u2019s disease. Acta Neurol Belg 114:25\u201331. doi: 10.1007\/s13760-013-0223-5","journal-title":"Acta Neurol Belg"},{"key":"267_CR115","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00415-005-0747-6","volume":"252","author":"J Berciano","year":"2005","unstructured":"Berciano J, Ferrer I (2005) Glial cell cytoplasmic inclusions in SCA2 do not express alpha-synuclein. J Neurol 252:742\u2013744. doi: 10.1007\/s00415-005-0747-6","journal-title":"J Neurol"},{"key":"267_CR116","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/ana.20389","volume":"57","author":"SA Factor","year":"2005","unstructured":"Factor SA, Qian J, Lava NS et al (2005) False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy. Ann Neurol 57:462\u2013463. doi: 10.1002\/ana.20389","journal-title":"Ann Neurol"},{"key":"267_CR117","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/brain\/awh535","volume":"128","author":"C Kamm","year":"2005","unstructured":"Kamm C, Healy DG, Quinn NP et al (2005) The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group. Brain J Neurol 128:1855\u20131860. doi: 10.1093\/brain\/awh535","journal-title":"Brain J Neurol"},{"key":"267_CR118","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00234-001-0713-7","volume":"44","author":"H Naka","year":"2002","unstructured":"Naka H, Ohshita T, Murata Y et al (2002) Characteristic MRI findings in multiple system atrophy: comparison of the three subtypes. Neuroradiology 44:204\u2013209","journal-title":"Neuroradiology"},{"key":"267_CR119","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000072856","volume":"100","author":"PJ Hagerman","year":"2003","unstructured":"Hagerman PJ, Greco CM, Hagerman RJ (2003) A cerebellar tremor\/ataxia syndrome among fragile X premutation carriers. Cytogenet Genome Res 100:206\u2013212 72856","journal-title":"Cytogenet Genome Res"},{"key":"267_CR120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jns.2004.08.013","volume":"227","author":"EM Garland","year":"2004","unstructured":"Garland EM, Vnencak-Jones CL, Biaggioni I et al (2004) Fragile X gene premutation in multiple system atrophy. J Neurol Sci 227:115\u2013118. doi: 10.1016\/j.jns.2004.08.013","journal-title":"J Neurol Sci"},{"key":"267_CR121","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00415-004-0546-5","volume":"251","author":"I Yabe","year":"2004","unstructured":"Yabe I, Soma H, Takei A et al (2004) No association between FMR1 premutations and multiple system atrophy. J Neurol 251:1411\u20131412. doi: 10.1007\/s00415-004-0546-5","journal-title":"J Neurol"},{"key":"267_CR122","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","volume":"461","author":"TA Manolio","year":"2009","unstructured":"Manolio TA, Collins FS, Cox NJ et al (2009) Finding the missing heritability of complex diseases. Nature 461:747\u2013753. doi: 10.1038\/nature08494","journal-title":"Nature"},{"key":"267_CR123","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1756-6606-4-24","volume":"4","author":"H Sasaki","year":"2011","unstructured":"Sasaki H, Emi M, Iijima H et al (2011) Copy number loss of (src homology 2 domain containing)-transforming protein 2 (SHC2) gene: discordant loss in monozygotic twins and frequent loss in patients with multiple system atrophy. Mol Brain 4:24. doi: 10.1186\/1756-6606-4-24","journal-title":"Mol Brain"},{"key":"267_CR124","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10286-013-0216-8","volume":"24","author":"MC Ferguson","year":"2014","unstructured":"Ferguson MC, Garland EM, Hedges L et al (2014) SHC2 gene copy number in multiple system atrophy (MSA). Clin Auton Res Off J Clin Auton Res Soc 24:25\u201330. doi: 10.1007\/s10286-013-0216-8","journal-title":"Clin Auton Res Off J Clin Auton Res Soc"},{"key":"267_CR125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1086\/431652","volume":"77","author":"AJ Sharp","year":"2005","unstructured":"Sharp AJ, Locke DP, McGrath SD et al (2005) Segmental duplications and copy-number variation in the human genome. Am J Hum Genet 77:78\u201388. doi: 10.1086\/431652","journal-title":"Am J Hum Genet"},{"key":"267_CR126","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng.345","volume":"41","author":"CN Henrichsen","year":"2009","unstructured":"Henrichsen CN, Vinckenbosch N, Z\u00f6llner S et al (2009) Segmental copy number variation shapes tissue transcriptomes. Nat Genet 41:424\u2013429. doi: 10.1038\/ng.345","journal-title":"Nat Genet"},{"key":"267_CR127","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ajhg.2007.12.011","volume":"82","author":"CEG Bruder","year":"2008","unstructured":"Bruder CEG, Piotrowski A, Gijsbers AACJ et al (2008) Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am J Hum Genet 82:763\u2013771. doi: 10.1016\/j.ajhg.2007.12.011","journal-title":"Am J Hum Genet"},{"key":"267_CR128","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/mds.21671","volume":"22","author":"N Stefanova","year":"2007","unstructured":"Stefanova N, Reindl M, Neumann M et al (2007) Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy. Mov Disord Off J Mov Disord Soc 22:2196\u20132203. doi: 10.1002\/mds.21671","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"267_CR129","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1042\/BST0351127","volume":"35","author":"ML Block","year":"2007","unstructured":"Block ML, Hong J-S (2007) Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem Soc Trans 35:1127\u20131132. doi: 10.1042\/BST0351127","journal-title":"Biochem Soc Trans"},{"key":"267_CR130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1471-4159.2010.06611.x","volume":"113","author":"A Brand","year":"2010","unstructured":"Brand A, Bauer NG, Hallott A et al (2010) Membrane lipid modification by polyunsaturated fatty acids sensitizes oligodendroglial OLN-93 cells against oxidative stress and promotes up-regulation of heme oxygenase-1 (HSP32). J Neurochem 113:465\u2013476. doi: 10.1111\/j.1471-4159.2010.06611.x","journal-title":"J Neurochem"},{"key":"267_CR131","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12640-011-9294-3","volume":"21","author":"N Stefanova","year":"2012","unstructured":"Stefanova N, Georgievska B, Eriksson H et al (2012) Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model. Neurotox Res 21:393\u2013404. doi: 10.1007\/s12640-011-9294-3","journal-title":"Neurotox Res"},{"key":"267_CR132","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainres.2010.02.045","volume":"1326","author":"S Bukhatwa","year":"2010","unstructured":"Bukhatwa S, Zeng B-Y, Rose S, Jenner P (2010) A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy. Brain Res 1326:174\u2013183. doi: 10.1016\/j.brainres.2010.02.045","journal-title":"Brain Res"},{"key":"267_CR133","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12031-012-9733-5","volume":"47","author":"L Schwarz","year":"2012","unstructured":"Schwarz L, Goldbaum O, Bergmann M et al (2012) Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes. J Mol Neurosci MN 47:256\u2013266. doi: 10.1007\/s12031-012-9733-5","journal-title":"J Mol Neurosci MN"},{"key":"267_CR134","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.febslet.2009.12.047","volume":"584","author":"VI Korolchuk","year":"2010","unstructured":"Korolchuk VI, Menzies FM, Rubinsztein DC (2010) Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett 584:1393\u20131398. doi: 10.1016\/j.febslet.2009.12.047","journal-title":"FEBS Lett"},{"key":"267_CR135","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1523\/JNEUROSCI.1560-11.2011","volume":"31","author":"D Ebrahimi-Fakhari","year":"2011","unstructured":"Ebrahimi-Fakhari D, Cantuti-Castelvetri I, Fan Z et al (2011) Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of \u03b1-synuclein. J Neurosci Off J Soc Neurosci 31:14508\u201314520. doi: 10.1523\/JNEUROSCI.1560-11.2011","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"267_CR136","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4161\/auto.1.1.1513","volume":"1","author":"DC Rubinsztein","year":"2005","unstructured":"Rubinsztein DC, DiFiglia M, Heintz N et al (2005) Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 1:11\u201322","journal-title":"Autophagy"},{"key":"267_CR137","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00401-012-0977-5","volume":"124","author":"N Stefanova","year":"2012","unstructured":"Stefanova N, Kaufmann WA, Humpel C et al (2012) Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human \u03b1-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. Acta Neuropathol (Berl) 124:51\u201365. doi: 10.1007\/s00401-012-0977-5","journal-title":"Acta Neuropathol (Berl)"},{"key":"267_CR138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-012-9358-z","volume":"23","author":"MB Wong","year":"2013","unstructured":"Wong MB, Goodwin J, Norazit A et al (2013) SUMO-1 is associated with a subset of lysosomes in glial protein aggregate diseases. Neurotox Res 23:1\u201321. doi: 10.1007\/s12640-012-9358-z","journal-title":"Neurotox Res"},{"key":"267_CR139","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ng.859","volume":"43","author":"GU H\u00f6glinger","year":"2011","unstructured":"H\u00f6glinger GU, Melhem NM, Dickson DW et al (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 43:699\u2013705. doi: 10.1038\/ng.859","journal-title":"Nat Genet"},{"key":"267_CR140","doi-asserted-by":"crossref","first-page":"D1001","DOI":"10.1093\/nar\/gkt1229","volume":"42","author":"D Welter","year":"2014","unstructured":"Welter D, Macarthur J, Morales J et al (2014) The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 42:D1001\u2013D1006. doi: 10.1093\/nar\/gkt1229","journal-title":"Nucleic Acids Res"},{"key":"267_CR141","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1093\/hmg\/dds335","volume":"21","author":"MF Keller","year":"2012","unstructured":"Keller MF, Saad M, Bras J et al (2012) Using genome-wide complex trait analysis to quantify \u201cmissing heritability\u201d in Parkinson\u2019s disease. Hum Mol Genet 21:4996\u20135009. doi: 10.1093\/hmg\/dds335","journal-title":"Hum Mol Genet"},{"key":"267_CR142","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/gm461","volume":"5","author":"JR Lupski","year":"2013","unstructured":"Lupski JR, Gonzaga-Jauregui C, Yang Y et al (2013) Exome sequencing resolves apparent incidental findings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Tooth neuropathy. Genome Med 5:57. doi: 10.1186\/gm461","journal-title":"Genome Med"},{"key":"267_CR143","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2350-13-3","volume":"13","author":"DS Lieber","year":"2012","unstructured":"Lieber DS, Vafai SB, Horton LC et al (2012) Atypical case of Wolfram syndrome revealed through targeted exome sequencing in a patient with suspected mitochondrial disease. BMC Med Genet 13:3. doi: 10.1186\/1471-2350-13-3","journal-title":"BMC Med Genet"},{"key":"267_CR144","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ajhg.2011.11.003","volume":"89","author":"I Ionita-Laza","year":"2011","unstructured":"Ionita-Laza I, Makarov V, Yoon S et al (2011) Finding disease variants in Mendelian disorders by using sequence data: methods and applications. Am J Hum Genet 89:701\u2013712. doi: 10.1016\/j.ajhg.2011.11.003","journal-title":"Am J Hum Genet"},{"key":"267_CR145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev-med-051010-162644","volume":"63","author":"C Gonzaga-Jauregui","year":"2012","unstructured":"Gonzaga-Jauregui C, Lupski JR, Gibbs RA (2012) Human genome sequencing in health and disease. Annu Rev Med 63:35\u201361. doi: 10.1146\/annurev-med-051010-162644","journal-title":"Annu Rev Med"},{"key":"267_CR146","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J et al (2013) TREM2 variants in Alzheimer\u2019s disease. N Engl J Med 368:117\u2013127. doi: 10.1056\/NEJMoa1211851","journal-title":"N Engl J Med"},{"key":"267_CR147","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.gde.2009.04.010","volume":"19","author":"NJ Schork","year":"2009","unstructured":"Schork NJ, Murray SS, Frazer KA, Topol EJ (2009) Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 19:212\u2013219. doi: 10.1016\/j.gde.2009.04.010","journal-title":"Curr Opin Genet Dev"},{"key":"267_CR148","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2013.09.006","volume":"155","author":"DC Koboldt","year":"2013","unstructured":"Koboldt DC, Steinberg KM, Larson DE et al (2013) The next-generation sequencing revolution and its impact on genomics. Cell 155:27\u201338. doi: 10.1016\/j.cell.2013.09.006","journal-title":"Cell"},{"key":"267_CR149","first-page":"565","volume":"15","author":"RC Green","year":"2013","unstructured":"Green RC, Berg JS, Grody WW et al (2013) ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med Off J Am Coll Med Genet 15:565\u2013574. doi: 10.1038\/gim.2013.73","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"267_CR150","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ejhg.2013.46","volume":"21","author":"CG El Van","year":"2013","unstructured":"Van El CG, Cornel MC, Borry P et al (2013) Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. Eur J Hum Genet EJHG 21:580\u2013584. doi: 10.1038\/ejhg.2013.46","journal-title":"Eur J Hum Genet EJHG"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-014-0267-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10286-014-0267-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-014-0267-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T07:20:49Z","timestamp":1717744849000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10286-014-0267-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["267"],"URL":"https:\/\/doi.org\/10.1007\/s10286-014-0267-5","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}